Expertise in
5
conditions

Bridget E. Griffiths

Newcastle Upon Tyne, ENG, GB 
Expertise in
5
conditions
Newcastle Upon Tyne, ENG, GB 
OverviewLocationsClinical Research

Overview

Bridget Griffiths practices in Newcastle Upon Tyne, United Kingdom. Ms. Griffiths is highly rated in 5 conditions, according to our data. Her top areas of expertise are Dry Mouth, Sjogren Syndrome, Systemic Sclerosis (SSc), Scleroderma, and Hernia Surgery.

Her clinical research consists of co-authoring 90 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

Newcastle Upon Tyne, ENG, United Kingdom
Other Locations
Neston, ENG CH647TE, United Kingdom
IC2 Liverpool Science Park, Liverpool, ENG L35RF, United Kingdom
Manchester, ENG, United Kingdom
London, ENG, United Kingdom
Chester High Road, Chester, ENG CH647TE, United Kingdom
Countess Wear, ENG, United Kingdom
St James's University Hospital
St James's, ENG, United Kingdom
The General Infirmary at Leeds
Leeds, ENG LS13EX, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomised Prospective Open Label Pilot Trial Comparing Mycophenolate Mofetil (MMF) With no Immunosuppression in Adults With Limited Cutaneous Systemic Sclerosis
A Randomised Prospective Open Label Pilot Trial Comparing Mycophenolate Mofetil (MMF) With no Immunosuppression in Adults With Limited Cutaneous Systemic Sclerosis
Enrollment Status: Unknown
Publish Date: July 27, 2023
Intervention Type: Drug
Study Drug: Mycophenolate Mofetil 
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
Enrollment Status: Terminated
Publish Date: March 29, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
View 1 Less Clinical Trial

90 Total Publications

Defining Standard Data Reporting in Pelvic Exenterations for Non-Rectal Cancers: A Systematic Review of Current Data Reporting.
Defining Standard Data Reporting in Pelvic Exenterations for Non-Rectal Cancers: A Systematic Review of Current Data Reporting.
Journal: Cancers
Published: July 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Griffiths's expertise for a condition
ConditionClose
      View All 18 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile